Xiang Zhou

8PUBLICATIONS
12CO-AUTHORS
Food properties (incl. characteristics and health benefits)Disease surveillanceRegenerative medicine (incl. stem cells)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 13, 2023
Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19.

Liuying Chen, Zhongwei Yin, Dan Zhou

|Aug 14, 2023
Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies.

Wenjing Zhang, Fan Du, Li Wang

|Nov 19, 2021
Salvage therapy with "Dara-KDT-P(A)CE" in heavily pretreated, high-risk, proliferative, relapsed/refractory multiple myeloma.

Xiang Zhou, Anna Ruckdeschel, Jessica Peter

|Feb 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns.

Sophia Danhof, Leo Rasche, Anja Mottok

|Dec 23, 2020
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma.

Maximilian Johannes Steinhardt, Xiang Zhou, Franziska Krummenast

|Jan 22, 2020
Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.

Xiang Zhou, Patrick Wuchter, Gerlinde Egerer

Pageof 2

Frequent Collaborators

2 joint publications

Patrick Wuchter

2 joint publications

Katharina Kriegsmann

1 joint publications

Klaus Martin Kortüm

1 joint publications

Sophia Danhof